ARCHIVES

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 22 | June 5, 1998

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

Black Women More Likely To Delay Diagnosis, Treatment

July 29, 2005

Abstracts Of Papers For Therapeutic Radiologists Meeting

November 7, 1975

Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment

February 2, 1996

Fisher To Direct Wilmot CC

October 5, 2001

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014